Overview

Antagonist Protocol in IVF

Status:
Unknown status

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

The antagonist protocol in a novel method of stimulation in the in vitro fertilization (IVF) patients. It has been tried in poor responders, polycystic ovary (PCO) patients and normal females undergoing IVF. Can it be used with the same efficacy in all patients?

Phase:

Phase 2

Details

Lead Sponsor:

Woman's Health University Hospital, Egypt

Collaborator:

Cairo University

Treatments:

Cetrorelix
Hormone Antagonists
Hormones
Menotropins